Avaleht › Eesnäärmevähk › Washington
Eesnäärmevähk kliinilised uuringud osariigis Washington
51 uuringut haiguse Eesnäärmevähk jaoks otsivad osalejaid osariigis Washington.
Linnad osariigis Washington
- Seattle42 uuringut
- Tacoma11 uuringut
- Spokane Valley9 uuringut
- Spokane6 uuringut
- Kirkland5 uuringut
- Bellingham5 uuringut
- Renton5 uuringut
- Everett4 uuringut
- Walla Walla4 uuringut
- Vancouver4 uuringut
- Kennewick4 uuringut
- Longview4 uuringut
Ametlik uuringutekst (inglise keeles)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1/2
Vanused 12 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- ja veel 19
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Swedish Medical Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 28. sept 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- University of Washington, Seattle
VärbamineVaatlusuuring
Vanused 18–120 · Mehed · Uuendatud 28. sept 2026 · NCT04706663Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Research Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 25. sept 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Spokane Urology ( Site 0035), Spokane
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT06136650A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 25. sept 2026 · NCT07082920This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Northwest Medical Specialties, PLLC, Bonney Lake
- Northwest Medical Specialties, PLLC, Federal Way
- Northwest Medical Specialties, PLLC, Gig Harbor
- ja veel 2
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 24. sept 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fred Hutchinson Cancer Research Center, Seattle
VärbamineFaas 2/3
Vanused 18–100 · Mehed · Uuendatud 22. sept 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Northwest Medical Specialties, PLLC, Tacoma
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 22. sept 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Swedish Medical Center, Seattle
- Northwest Medical Specialties, Tacoma
VärbamineFaas 3
Vanused 18–100 · Mehed · Uuendatud 22. sept 2026 · NCT06855277High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 17. sept 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 17. sept 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 17. sept 2026 · NCT06925737PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- University of Washington Medical Center, Seattle
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Mehed · Uuendatud 15. sept 2026 · NCT04995198The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- University of Washington, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 14. sept 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 10. sept 2026 · NCT05946213Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 10. sept 2026 · NCT05997615Prostate Active Surveillance Study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
VärbamineVaatlusuuring
Vanused 21 ja vanemad · Mehed · Uuendatud 2. sept 2026 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
VärbamineTerved vabatahtlikud oodatud
Vanused 45–75 · Kõik sood · Uuendatud 2. sept 2026 · NCT06995898Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 27. aug 2026 · NCT07698535AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Tacoma
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 26. aug 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 25. aug 2026 · NCT05593497Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Washington Medical Center, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 24. aug 2026 · NCT07745361A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 21. aug 2026 · NCT06844383Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 21. aug 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- ja veel 19
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 19. aug 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 17. aug 2026 · NCT06842498Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 14. aug 2026 · NCT04812366Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Mehed · Uuendatud 12. aug 2026 · NCT04489719Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 1/2
Vanused 18 ja vanemad · Mehed · Uuendatud 11. aug 2026 · NCT06236139A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 10. aug 2026 · NCT06067841Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
Kõik vanused · Mehed · Uuendatud 6. aug 2026 · NCT06145633Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Mehed · Uuendatud 6. aug 2026 · NCT01050504Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 31. juuli 2026 · NCT06613100Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 21. juuli 2026 · NCT06039371Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Värbamine
Vanused 18 ja vanemad · Mehed · Uuendatud 15. juuli 2026 · NCT05918263Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Providence Regional Cancer System-Aberdeen, Aberdeen
- FHCC Overlake, Bellevue
- PeaceHealth Saint Joseph Medical Center, Bellingham
- ja veel 22
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 14. juuli 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- University of Washington, Fred Hutchinson Cancer Center, Seattle
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 9. juuli 2026 · NCT05413421Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.